中文/ EN

Main Business
Scientific Affairs

Scientific Affairs

  • Medical Registration Filing
  • Clinical Development Strategy
  • Medical Monitoring
  • Medical Writing
  • Medical Review
  • Pharmacovigilance
Clinical Operations

Clinical Operations

  • BE & Phase I Clinical
  • Phase II and III Clinical
  • Project Management
  • Quality Management
  • Service Outposting
Third Party Audit

Third Party Audit

  • Clinical Trial Site Audit
  • Audit Of The Quality System Of Clinical Trial Institutes & Research Centres
  • Audit Of Test Data Management & Statistical Management
  • Audit Of Third-Party Clinical Trial Service Providers
Data Statistics

Data Statistics

  • Biological Sample Analysis Method Development
  • Validation of Analytical Methods for Biological Samples
  • Sample Analysis
  • Data Management and Locking
  • Statistical Analysis
News

Prof. Zhen Xuechu, Chairman of Biyi Clinical, was invited to participate in the Taicang Biomedical Industry Innovation Cluster Development Conference. On the afternoon of May 25, 2022, Taicang City held a conference on the development of innovation clusters in the biopharmaceutical industry, and the Institute of Clinical Pharmacology Technology of S

View Details

Prof. Zhen Xuechu, Chairman of Biyi Clinical, was invited to participate in the Taicang Biomedical Industry Innovation Cluster Development Conference. On the afternoon of May 25, 2022, Taicang City held a conference on the development of innovation clusters in the biopharmaceutical industry, and the Institute of Clinical Pharmacology Technology of S

View Details

Prof. Zhen Xuechu, Chairman of Biyi Clinical, was invited to participate in the Taicang Biomedical Industry Innovation Cluster Development Conference. On the afternoon of May 25, 2022, Taicang City held a conference on the development of innovation clusters in the biopharmaceutical industry, and the Institute of Clinical Pharmacology Technology of S

View Details

Prof. Zhen Xuechu, Chairman of Biyi Clinical, was invited to participate in the Taicang Biomedical Industry Innovation Cluster Development Conference. On the afternoon of May 25, 2022, Taicang City held a conference on the development of innovation clusters in the biopharmaceutical industry, and the Institute of Clinical Pharmacology Technology of S

View Details
Business Advantages
Efficient Clinical Operations Capabilities
Project implementation of flat management, senior management down to the project line, the team's rapid response, strong executive force
The Yangtze River Delta region is rich in clinical resources
Accurate and efficient docking of clinical expert resources to assist in solving clinical research pain point problems
Complete team support system
Complete management system, sound talent retention program to ensure the quality and quantity of personnel
Excellent quality management system
Rich resources of audit experts and complete quality control system reliably prevent the risks of the project.
First-class medical statistics in China
Led by domestic well-known statistical experts, with experienced personnel and first-class software and hardware strengths
Professional medical team support
Complete medical strategy services, professional level medical audit system
High level of testing and analyzing capability
Can provide scientific, rigorous, efficient and personalized testing and analysis solutions
Quality price/performance ratio
High quality and cost-effective to make you a better choice trust us, trust Biyi.
Approved Products
Tenofovir disoproxil fumarate tablets
Xtandi
Montelukast Sodium Granules
Tenofovir disoproxil fumarate tablets
Levonorgestrel Tablets
Cooperative Partner